Groundbreaking technology from PeraHealth that monitors patient health and flags up anomalies has been given the green light by the Food and Drug Administration (FDA).
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
